XML 53 R43.htm IDEA: XBRL DOCUMENT v3.22.2
Revenue - Business Revenue (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jun. 25, 2022
Jun. 26, 2021
Jun. 25, 2022
Jun. 26, 2021
Disaggregation of Revenue [Line Items]        
Revenues $ 1,002.7 $ 1,168.3 $ 3,909.6 $ 4,315.7
Contract with Customer, Liability, Revenue Recognized 21.4 20.1 108.7 100.9
United States        
Disaggregation of Revenue [Line Items]        
Revenues 734.6 749.9 2,739.4 2,951.7
International        
Disaggregation of Revenue [Line Items]        
Revenues 268.1 418.4 1,170.2 1,364.0
Diagnostics        
Disaggregation of Revenue [Line Items]        
Revenues 560.1 665.5 2,497.6 2,858.2
Diagnostics | United States        
Disaggregation of Revenue [Line Items]        
Revenues 387.4 357.2 1,647.8 1,825.8
Diagnostics | International        
Disaggregation of Revenue [Line Items]        
Revenues 172.7 308.3 849.8 1,032.4
Diagnostics | Cytology & Perinatal        
Disaggregation of Revenue [Line Items]        
Revenues 115.9 115.9 362.0 357.9
Diagnostics | Cytology & Perinatal | United States        
Disaggregation of Revenue [Line Items]        
Revenues 74.3 73.9 227.4 230.8
Diagnostics | Cytology & Perinatal | International        
Disaggregation of Revenue [Line Items]        
Revenues 41.6 42.0 134.6 127.1
Diagnostics | Molecular Diagnostics        
Disaggregation of Revenue [Line Items]        
Revenues 435.3 536.4 2,111.1 2,467.0
Diagnostics | Molecular Diagnostics | United States        
Disaggregation of Revenue [Line Items]        
Revenues 304.2 270.1 1,395.9 1,561.7
Diagnostics | Molecular Diagnostics | International        
Disaggregation of Revenue [Line Items]        
Revenues 131.1 266.3 715.2 905.3
Diagnostics | Blood Screening        
Disaggregation of Revenue [Line Items]        
Revenues 8.9 13.2 24.5 33.3
Diagnostics | Blood Screening | United States        
Disaggregation of Revenue [Line Items]        
Revenues 8.9 13.2 24.5 33.3
Diagnostics | Blood Screening | International        
Disaggregation of Revenue [Line Items]        
Revenues 0.0 0.0 0.0 0.0
Breast Health        
Disaggregation of Revenue [Line Items]        
Revenues 282.8 349.0 952.7 1,018.0
Breast Health | United States        
Disaggregation of Revenue [Line Items]        
Revenues 222.3 273.2 732.9 784.4
Breast Health | International        
Disaggregation of Revenue [Line Items]        
Revenues 60.5 75.8 219.8 233.6
Breast Health | Breast Imaging        
Disaggregation of Revenue [Line Items]        
Revenues 212.2 280.3 739.5 817.8
Breast Health | Breast Imaging | United States        
Disaggregation of Revenue [Line Items]        
Revenues 165.5 218.4 561.8 619.5
Breast Health | Breast Imaging | International        
Disaggregation of Revenue [Line Items]        
Revenues 46.7 61.9 177.7 198.3
Breast Health | Interventional Breast Solutions        
Disaggregation of Revenue [Line Items]        
Revenues 70.6 68.7 213.2 200.2
Breast Health | Interventional Breast Solutions | United States        
Disaggregation of Revenue [Line Items]        
Revenues 56.8 54.8 171.1 164.9
Breast Health | Interventional Breast Solutions | International        
Disaggregation of Revenue [Line Items]        
Revenues 13.8 13.9 42.1 35.3
GYN Surgical        
Disaggregation of Revenue [Line Items]        
Revenues 138.1 127.9 389.6 366.2
GYN Surgical | United States        
Disaggregation of Revenue [Line Items]        
Revenues 112.2 103.9 315.4 296.8
GYN Surgical | International        
Disaggregation of Revenue [Line Items]        
Revenues 25.9 24.0 74.2 69.4
Skeletal Health        
Disaggregation of Revenue [Line Items]        
Revenues 21.7 25.9 69.7 73.3
Skeletal Health | United States        
Disaggregation of Revenue [Line Items]        
Revenues 12.7 15.6 43.3 44.7
Skeletal Health | International        
Disaggregation of Revenue [Line Items]        
Revenues $ 9.0 $ 10.3 $ 26.4 $ 28.6